🎉 M&A multiples are live!
Check it out!

Treatment AI Valuation Multiples

Discover revenue and EBITDA valuation multiples for Treatment AI and similar public comparables like Echo IQ, Benevolent AI, and Alcidion Group.

Treatment AI Overview

About Treatment AI

Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.


Founded

2018

HQ

Canada
Employees

n/a

Website

treatment.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$14.7M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Treatment AI Financials

Treatment AI has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Treatment AI achieved revenue of n/a and an EBITDA of -$2.6M.

Treatment AI expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Treatment AI valuation multiples based on analyst estimates

Treatment AI P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$2.6M -$2.6M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$9.7M -$2.7M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a $0.4M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Treatment AI Stock Performance

As of April 1, 2025, Treatment AI's stock price is CAD 0 (or $0).

Treatment AI has current market cap of CAD 21.1M (or $14.7M), and EV of CAD 21.0M (or $14.7M).

See Treatment AI trading valuation data

Treatment AI Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$14.7M $14.7M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Treatment AI Valuation Multiples

As of April 1, 2025, Treatment AI has market cap of $14.7M and EV of $14.7M.

Treatment AI's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Treatment AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Treatment AI and 10K+ public comps

Treatment AI Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $14.7M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -5.7x XXX XXX XXX
P/E -5.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -28.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Treatment AI Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Treatment AI Valuation Multiples

Treatment AI's NTM/LTM revenue growth is n/a

Treatment AI's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Treatment AI's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Treatment AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Treatment AI and other 10K+ public comps

Treatment AI Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -3% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Treatment AI Public Comps

See public comps and valuation multiples for Healthcare Software and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Benevolent AI XXX XXX XXX XXX XXX XXX
Alcidion Group XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Doctor Care Anywhere XXX XXX XXX XXX XXX XXX
Echo IQ XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Treatment AI M&A and Investment Activity

Treatment AI acquired  XXX companies to date.

Last acquisition by Treatment AI was  XXXXXXXX, XXXXX XXXXX XXXXXX . Treatment AI acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Treatment AI

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Treatment AI

When was Treatment AI founded? Treatment AI was founded in 2018.
Where is Treatment AI headquartered? Treatment AI is headquartered in Canada.
Is Treatment AI publicy listed? Yes, Treatment AI is a public company listed on CNQ.
What is the stock symbol of Treatment AI? Treatment AI trades under TRUE ticker.
When did Treatment AI go public? Treatment AI went public in 2021.
Who are competitors of Treatment AI? Similar companies to Treatment AI include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere.
What is the current market cap of Treatment AI? Treatment AI's current market cap is $14.7M
Is Treatment AI profitable? Yes, Treatment AI is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.